HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HCID 97653Erstellt: 3. November 2026
Dichlorotrimethylantimon
Nsc140285 · Trimethyldichlorostibine · Trimethyldichloroantimony · Dichlorotrimethylantimony · Antimony,dichlorotrimethyl- · Antimony, dichlorotrimethyl- · Trimethyldichloroantimony(V) · Dichlorotrimethylantimony(V)
https://huagongshe.com/de/chemical/97653
Identifikatoren & physikalische Daten
| CAS No. | 13059-67-1 |
|---|
| Summenformel | C3H9Cl2Sb |
|---|
| Durchschnittliche Molmasse | 237,77 g/mol |
|---|
| Monoisotopische Masse | 235,91194 g/mol |
|---|
| SMILES | [CH3][Sb]([CH3])([CH3])([Cl])[Cl] |
|---|
| InChIKey | IEOZXTYTNPKDKQ-UHFFFAOYSA-L |
|---|
| PubChem CID | 97653 |
|---|
| EC No. | 235-952-8 |
|---|
| DTXSID | DTXSID80156630 |
|---|
| Lokaler Name | Dichlorotrimethylantimon |
|---|
Chemische & physikalische Eigenschaften
| Polarare Oberfläche (TPSA) | 0 |
|---|
| H-Brücken-Donoren | 0 |
|---|
| H-Brücken-Akzeptoren | 0 |
|---|
| Frei drehbare Bindungen | 0 |
|---|
| Schwere Atome | 6 |
|---|
| Formalladung | 0 |
|---|
| Komplexität | 54,9 |
|---|
| Schmelzpunkt | 222-223 °C (dec.)(lit.) |
|---|
Sicherheit & Vorschriften
| Treatment | Following oral exposure to antimony, administer charcoal as a slurry (240 mL water/30 g charcoal). Following inhalation exposure, move patient to fresh air. Monitor for respiratory distress. If cough or difficulty breathing develops, evaluate for respiratory tract irritation, bronchitis, or pneumonitis. Administer oxygen and assist ventilation as required. Treat bronchospasm with inhaled beta2 agonist and oral or parenteral corticosteroids. In case of eye exposure, irrigate exposed eyes with copious amounts of room temperature water for at least 15 minutes. Following dermal exposure, Remove contaminated clothing and wash exposed area thoroughly with soap and water. A physician may need to examine the area if irritation or pain persists. (T36) |
|---|
| Gesundheitliche Auswirkungen | Dermal exposure to antimony can cause antimony spots (papules and pustules around sweat and sebaceous glands). Antimony poisoning can also lead to pneumoconiosis. Alterations in pulmonary function and other effects including chronic bronchitis, chronic emphysema, inactive tuberculosis, pleural adhesions, and irritation can result from inhalation of antimony. Increased blood pressure can also result from antimony poisoning. Myocardial depression, vasodilation and fluid loss may cause shock with hypotension, electrolyte disturbances and acute renal failure. Cerebral oedema, coma, convulsions, and death are possible. (L741) |
|---|
| Expositionspfade | Inhalation (L741)oral (L741)dermal (L741) |
|---|
| Toxizitätsübersicht | The inhalation data suggests that the myocardium is a target of antimony toxicity. It is possible that antimony affects circulating glucose by interfering with enzymes of the glycogenolysis and gluconeogenesis pathways. The mechanism of action of antimony remains unclear. However, some studies suggest that antimony combines with sulfhydryl groups including those in several enzymes important for tissue respiration. The antidotal action of BAL depends on its ability to prevent or break the union between antimony and vital enzymes. Moreover, the The cause of death is believed to be essentially the same as that in acute arsenic poisoning. (T18, L741, A238) |
|---|
| Signs and Symptoms | Abdominal pain, vomiting, diarrhea can result from inhalation of antimony. Dyspnea, headache, vomiting,cough, conjunctivitis, and bloody purulent discharge from nose can result from inhalation exposure. Skin or eye contact can cause pain and redness of the exposed surface. (T64, L741) |
|---|
| Carcinogen Classification |
|---|